Every SEC Form 3/4/5 on record for this filer (CIK 1216955) — 6 issuers, 239 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ARE | ALEXANDRIA REAL ESTATE EQUITIES, INC. | Executive Chairman · Director | 2015-07-01 → 2026-05-07 | 86 | −$105M |
| ITCI | Intra-Cellular Therapies, Inc. | Director | 2015-07-02 → 2025-04-02 | 38 | −$13M |
| APLT | Applied Therapeutics, Inc. | Director · lapsed | 2019-05-13 → 2024-06-07 | 16 | −$257,550 |
| FREQ | Frequency Therapeutics, Inc. | Director · lapsed | 2019-10-02 → 2022-08-19 | 12 | −$1M |
| MGTX | MeiraGTx Holdings plc | Director · lapsed | 2018-06-08 → 2022-06-09 | 8 | −$294,191 |
| ATRA | Atara Biotherapeutics, Inc. | Director · lapsed | 2016-01-05 → 2019-03-19 | 9 | −$3M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ARE | 2026-05-06 | Buy | 3,989 | $45.99 | $183,454 | 584,213 |
| ARE | 2026-05-06 | Buy | 3,511 | $46.74 | $164,104 | 587,724 |
| ARE | 2026-05-05 | Buy | 3,832 | $42.76 | $163,856 | 578,618 |
| ARE | 2026-05-05 | Buy | 1,606 | $43.70 | $70,182 | 580,224 |
| ARE | 2026-05-05 | Buy | 2,062 | $41.89 | $86,377 | 574,786 |
| ARE | 2026-05-04 | Buy | 10,000 | $41.02 | $410,200 | 572,724 |
| ARE | 2026-02-12 | Buy | 7,700 | $54.31 | $418,187 | 562,724 |
| ARE | 2026-02-12 | Buy | 17,300 | $53.74 | $929,702 | 555,024 |
3 of 6 issuers are covered and open a security page; the rest are on file here only.
